GLUE
NASDAQ · Biotechnology
Monte Rosa Therapeutics Inc
$12.61
+0.01 (+0.08%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Price Target
Analyst Price Target
+204.9% upside
Low Target
$28.40
Average Target
$38.45
High Target
$50.36
Current Price
$12.61
Current
$12.61
$12.61
Target
$38.45
$38.45
$28.40
$38.45 avg
$50.36
Scenario Analysis
Bear Case
$28.40
125.2%
Low target
Base Case
$38.45
+204.9%
Avg target
Bull Case
$50.36
+299.4%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$25.77
-51.1% from high
52-Week Low
$6.16
+104.7% from low
Target vs 52W High
$38.45
+49.2% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -2.8% |
| AMGN | Hold | 43 | 47% | $190.87 | -53.0% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +139.6% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -15.1% |
| REGN | Buy | 38 | 68% | $76.80 | -90.4% |
| MRNA | Hold | 30 | 37% | $149.45 | -17.9% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -63.4% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -40.2% |